
Mark V. Stevens
Examiner (ID: 4010, Phone: (571)270-7080 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1613 |
| Total Applications | 923 |
| Issued Applications | 533 |
| Pending Applications | 139 |
| Abandoned Applications | 300 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17733152
[patent_doc_number] => 20220218611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/702608
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702608 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | Mar 22, 2022 | Pending |
Array
(
[id] => 17685662
[patent_doc_number] => 20220192954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => DELIVERY OF SURFACTANT SOLUBLE ANTI-DANDRUFF AGENT
[patent_app_type] => utility
[patent_app_number] => 17/694270
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694270 | DELIVERY OF SURFACTANT SOLUBLE ANTI-DANDRUFF AGENT | Mar 13, 2022 | Pending |
Array
(
[id] => 17836334
[patent_doc_number] => 20220273639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PROCESSES FOR PREPARING ARIMOCLOMOL CITRATE AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/691989
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691989 | Processes for preparing arimoclomol citrate and intermediates thereof | Mar 9, 2022 | Issued |
Array
(
[id] => 18056396
[patent_doc_number] => 20220387482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PERFORMANCE ENHANCEMENT DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/803148
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17803148
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/803148 | PERFORMANCE ENHANCEMENT DELIVERY SYSTEM | Mar 3, 2022 | Abandoned |
Array
(
[id] => 19777499
[patent_doc_number] => 12226520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Self-fueled particles for propulsion through flowing aqueous fluids
[patent_app_type] => utility
[patent_app_number] => 17/687364
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 6104
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687364 | Self-fueled particles for propulsion through flowing aqueous fluids | Mar 3, 2022 | Issued |
Array
(
[id] => 19232051
[patent_doc_number] => 20240189242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/277346
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277346 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME | Feb 17, 2022 | Pending |
Array
(
[id] => 19232051
[patent_doc_number] => 20240189242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/277346
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277346 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME | Feb 17, 2022 | Pending |
Array
(
[id] => 17889763
[patent_doc_number] => 11452710
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-09-27
[patent_title] => Micronutrient and plant extract composition and method of improving bone health
[patent_app_type] => utility
[patent_app_number] => 17/674146
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5886
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674146 | Micronutrient and plant extract composition and method of improving bone health | Feb 16, 2022 | Issued |
Array
(
[id] => 19209621
[patent_doc_number] => 11998659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Bioimplant with evanescent coating film
[patent_app_type] => utility
[patent_app_number] => 17/673651
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6294
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673651 | Bioimplant with evanescent coating film | Feb 15, 2022 | Issued |
Array
(
[id] => 17944338
[patent_doc_number] => 20220331355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA
[patent_app_type] => utility
[patent_app_number] => 17/589838
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589838 | PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA | Jan 30, 2022 | Abandoned |
Array
(
[id] => 19570215
[patent_doc_number] => 20240374507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => COMPOSITIONS, DEVICES AND METHODS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE
[patent_app_type] => utility
[patent_app_number] => 18/274125
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274125 | COMPOSITIONS, DEVICES AND METHODS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE | Jan 25, 2022 | Pending |
Array
(
[id] => 17790269
[patent_doc_number] => 20220249360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Dedifferentiated cell extract of Bletilla and method for whitening, anti-oxidation and anti-wrinkling applying the same, and cosmetic comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/584691
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584691 | Dedifferentiated cell extract of | Jan 25, 2022 | Issued |
Array
(
[id] => 19032376
[patent_doc_number] => 20240082191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/273694
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273694 | TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS | Jan 23, 2022 | Pending |
Array
(
[id] => 18747058
[patent_doc_number] => 11806348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate
[patent_app_type] => utility
[patent_app_number] => 17/582516
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7914
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582516 | Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate | Jan 23, 2022 | Issued |
Array
(
[id] => 19032376
[patent_doc_number] => 20240082191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/273694
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273694 | TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS | Jan 23, 2022 | Pending |
Array
(
[id] => 19032376
[patent_doc_number] => 20240082191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/273694
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273694 | TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS | Jan 23, 2022 | Pending |
Array
(
[id] => 17958512
[patent_doc_number] => 20220339092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => COSMETIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/569715
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569715 | Cosmetic compositions and methods | Jan 5, 2022 | Issued |
Array
(
[id] => 17759844
[patent_doc_number] => 20220233456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/647149
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17647149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/647149 | Methods and compositions particularly for treatment of attention deficit disorder | Jan 4, 2022 | Issued |
Array
(
[id] => 17702846
[patent_doc_number] => 20220202852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS AND COMPOSITIONS OF AQUEOUS HYPOBROMOUS ACID FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/565348
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565348
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565348 | METHODS AND COMPOSITIONS OF AQUEOUS HYPOBROMOUS ACID FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY CONDITIONS | Dec 28, 2021 | Abandoned |
Array
(
[id] => 19018802
[patent_doc_number] => 20240074973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/269474
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269474 | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF | Dec 22, 2021 | Pending |